HOUSE-WELLNESS-FOODS
30.3.2021 12:32:10 CEST | Business Wire | Press release
Vietnam is a nation that has seen its share of turmoil and suffering over the past century, and emerged from it with strength, enthusiasm, dedicated to progress and self-sufficiency. Over the past 50 years its participation on the global stage has steadily risen, with ever-increased attention to commerce, health, and education.
As much as 35% of Vietnam’s aquacultural activity is built around river farming of the juvenile striped catfish [Pangasianodon hypophthalmus ] , making it the world’s largest producer of this nutritious staple, not only for its own consumption but for export to China, Europe, and elsewhere.
Vietnam’s story is one of many that expose the dual edge of farming to emerging populations. It’s been the keystone of civilization’s advancement since the dawn of humankind, but where resources are limited and need is great, farming’s potential hazards become viciously clear. Overstocked waters turn hazardous to human life due to excessive waste production and a rise in bacteria, parasites, fungi, and viruses. Overstocked waters produce fish that are increasingly malnourished, enervated, injured, and unable to reproduce.
The reflex response to this blight has been the use of antibiotics to keep weakened fish populations alive. Apart from expense, before long, disease-inducing agents mutate to resist the antibiotic, which, in turn, leads to the use of more varied antibiotics, causing a dangerous downward spiral . All the while antibiotics are entering the food chain and turning up in the human metabolic system to unpredictable, deleterious effect. Promise quickly turns to peril for the farmer, for the consumer, and for the future of vital aquaculture.
Feed LP20® can reverse this tide…
The details of this new study show its dramatic impact. In summary, researchers fed test stocks a diet supplemented with heat-killed Lactobacillus plantarum , strain L-137, the active ingredient in Feed LP20® . Key to the high effectiveness of Feed LP20® is the heat-killing process. It fully utilizes the strain’s characteristics, an area where House Wellness Foods holds an unparalleled position of authority based upon years of peer-reviewed testing and research, and continuous refinement of the development process. Heat treatment hardens bacillary cell walls and fixes their genetic material. Not only does this enable HK-L137 to resist initial breakdown in the upper gastric system, but it can be cooked, processed, stored, and administered in an aquatic environment without compromising potency. Further, both its ability to stimulate immune cytokine interleukin 12 and its shelf life far surpass that of any living lactobacillus supplement.
House Wellness Foods and the introduction of immunobiotics
Immunobiotics promote health by triggering immune responses in the mucosa. House Wellness Foods , one of Japan’s most trusted names in food production, began its exploration of immunobiotics and their ability to bolster human immune response, support liver function, and ameliorate the causes of chronic disease over three decades ago, and the culmination of their intensive research and meticulous development was their flagship Immuno-LP20® , with its active component of 20% heat-treated Lactobacillus plantarum L-137 (HK-L137). This potent lactobacillus follows a dual course on assimilation. It initiates production of signal molecule IL-12 and IFN-β cells — the latter being the most important single cytokine responsible for inhibiting viral multiplication; and it subsequently stimulates T cell activity and the production of both NK and cytotoxic T (CTL) effector cells, boosting innate immunity and fostering antibody creation as an adjunct to the adaptive immune response.
House followed the worldwide success of Immuno-LP20® , with the development of Feed LP20® , an alternative to antibiotics, and to the costly, unreliable, and lengthy process of cultivating disease-resistant strains of livestock. The overarching principle of immunobiotic therapy in both land-based and aquatic livestock is that the power to fight disease already exists within every living cell of the organism. Prior to the present study, Feed LP20® proved its remarkable effectiveness in other aquatic stock, including white leg shrimp and Nile tilapia . It recently began marketing in the EU as a complementary feed for poultry, swine, and salmonid.
The proof is in the food chain
The study shows that juvenile striped catfish fed HK-L137-supplemented diets exhibited higher final weight and specific growth rate than controlled stock given ordinary feed. The fish showed higher survival rate, longer life, better feed conversion ratios, weight gain, better protein efficiency ratios, and increased reproductive capacity. Further, a test sub-group was administered a bacterial challenge mirroring a real-life scenario in Vietnamese river farms of their most devastating bacterial threat, Bacillary Necrosis Disease (BNP), caused by the bacterial agent Edwardsiella ictaluri . Part of the test group was injected with this agent, and in every case the cumulative mortality of HK L-137-supplemented groups was lower than the group fed control diet.
Fitter fish, more successful farming, greater financial stability — all of this originating from the power of Feed LP20® , comprising 20% HK-L137 , to sustain health through enhanced immunity at the very cellular level. The new study shows the promise of House Wellness Foods’ Breakthrough Feed LP20®, and points to the future of a shared world that is often fragile, yet always filled with hope.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210330005016/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 01:00:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh
Spring is in Full Bloom at the Empire State Building with New Festive Experiences, Sweet Treats, and Seasonal Tower Lighting26.3.2026 21:30:00 CET | Press release
Spring is in full swing at the “World’s Most Famous Building.” The Empire State Building (ESB) today announced a vibrant lineup of spring events in NYC, which include special experiences, treat pop-ups, and an iconic tower lighting that captures the joy and color of the beautiful season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326216271/en/ Spring is in Full Bloom at the Empire State Building with New Festive Experiences, Sweet Treats, and Seasonal Tower Lighting “The Empire State Building Observation Deck has transformed into a celebration of the season and one of the best things to do in NYC this spring,” said Dan Rogoski, observatory general manager. “Whether it’s views beside our butterfly installation, sweet pop-ups, or a chance to spot the Easter Bunny, there is something special for every visitor.” Flutter of Color: The Empire State Building installed a brand-new photo opportunity on the 86th Floor Observati
Venture Global and Edison Announce Calcasieu Pass Arbitration Settlement26.3.2026 21:15:00 CET | Press release
Today, Venture Global and Edison jointly announced the signature of a commercial agreement for the settlement of the pending arbitration between the two companies concerning the Calcasieu Pass project. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326559130/en/ Completion of the settlement is expected by the end of Q2 2026, at which point the arbitration will be terminated. The agreement fully resolves the arbitration in its entirety. As part of the settlement, Edison and Venture Global have also agreed to the delivery to Europe of additional cargoes beyond those envisaged under the long-term contract, to support gas supplies primarily to the Italian market. The first delivery is scheduled for May 2026, in Italy, at the Adriatic LNG Terminal. The agreement represents a significant step in strengthening commercial cooperation between the parties and it establishes a foundation for further future deliveries in the context
Reply Recognized as a Microsoft Frontier Partner for Enterprise AI Delivery26.3.2026 19:06:00 CET | Press release
Reply [EXM, STAR: REY] announces it has been recognized as a Microsoft Frontier Partner within the Microsoft AI Cloud Partner Program, earning the Frontier Partner Badge for demonstrating advanced capabilities in delivering AI-first solutions across Cloud & AI Platforms, AI Business Solutions, and Security. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326965586/en/ The recognition reflects Reply’s capabilities across the Microsoft ecosystem, built through the work of its specialized companies – including Aim Reply, Business Elements Reply, Cluster Reply, Root16 Reply, Solidsoft Reply, Valorem Reply, WM Reply and Zest Reply – supporting enterprise organizations in designing, implementing, and operating AI solutions on Microsoft platforms across real-world business scenarios. The Frontier Partner badge recognizes partners that demonstrate advanced AI driven capabilities and meet rigorous badge requirements at the time of
SLB Announces Dates for First-Quarter 2026 Results Conference Call26.3.2026 18:00:00 CET | Press release
SLB (NYSE:SLB) will hold a conference call on April 24, 2026, to discuss the results for the first quarter ending March 31, 2026. The conference call is scheduled to begin at 11:00 a.m. US Eastern time and a press release regarding the results will be issued at 7:00 a.m. US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (833) 470-1428 within North America or +1 (404) 975-4839 outside of North America approximately 10 minutes prior to the start of the call and the access code is 742955. A webcast of the conference call will be broadcast simultaneously at https://events.q4inc.com/attendee/972985185 on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until May 1, 2026, and can be accessed by dialing +1 (866) 813-9403 within North America or +1 (929)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
